Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Colonic Neoplasms

Endometrial Neoplasms

Rectal Neoplasms

Endometrial Neoplasms

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Uterine Neoplasms, Endometrial Neoplasms

Colonic Neoplasms

Brain Neoplasms

Carcinoma, Non-Small-Cell Lung

Colonic Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Ovarian Carcinosarcoma

Locally Advanced Rectal Cancer (LARC)

Penile Neoplasms

Neoplasm Metastasis, Neoplasms, Sarcoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine

Colonic Neoplasms

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Turcot syndrome, Endometrial Neoplasms

Neoplasms, Recurrence, Neoplasms, Second Primary

Neoplasm Metastasis

Adenocarcinoma - GEJ

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

JADE

PanTumor-101

AZUR-4

BEHOLD-2

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

I-SPY

DOVE

BeeHive

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Superhero

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

ROCSAN

RW-NEDOS

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Pan-MSI-ACSE

NAIO

DOVIPA

RADIAN

PREDIR-NEOREC

SATELLITE

PREDOSTAR

IMPRESS-N

DEWI

PRIME